Research from Water Tower Research, Water Tower Research

Water Tower Research

Research from Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Equity Research Firm

Equity Bottom-Up

<div><ul><li>LFVN reported 3QFY26 results that were below our estimates and stated its FY26 revenue, EBITDA, and EPS are now expected to be at the lower end of its previously issued ranges. </li><li>Continued declines in the MindBody GLP-1 System customer cohort drove active accounts to 109k, their lowest level in several years, due to intensifying competition from pharmaceutical GLP-1 alternatives.</li><li>Revenue of $43.7MM declined 25.2% Y/Y, below our $47.8MM estimate. </li></ul></div>

LFVN reported 3QFY26 results that were below our estimates and stated its FY26 revenue, EBITDA, and EPS are now expected to be at the lower end of its previously issued ranges. Continued declines in the MindBody GLP-1 System customer cohort drove active accounts to 109k, their lowest level in several years, due to intensifying competition from pharmaceutical GLP-1 alternatives.Revenue of $43.7MM declined 25.2% Y/Y, below our $47.8MM estimate. 

LFVN: 3QFY26 Softer Than Anticipated; Incoming CEO Likely the Next Catalyst

<ul><li>LifeVantage has named Terrence Moorehead as its next President and CEO, effective August 5, 2026, a board-unanimous selection that reflects a deliberate and well-coordinated search for an operator whose specific skill set maps directly onto the opportunity ahead.</li><li>As detailed in our April 2 Management Series report, Steve Fife characterized the incoming CEO as inheriting a strong operational and financial foundation—a modernized comp plan, an engaged consultant community, and a differentiated product portfolio—well positioned to drive the company’s next growth phase.</li><li>Moorehead brings more than 25 years of direct selling and consumer products experience, with a career arc that uniquely combines global brand building, digital transformation, and field organization management.</li></ul>

LifeVantage has named Terrence Moorehead as its next President and CEO, effective August 5, 2026, a board-unanimous selection that reflects a deliberate and well-coordinated search for an operator whose specific skill set maps directly onto the opportunity ahead.As detailed in our April 2 Management Series report, Steve Fife characterized the incoming CEO as inheriting a strong operational and financial foundation—a modernized comp plan, an engaged consultant community, and a differentiated product portfolio—well positioned to drive the company’s next growth phase.Moorehead brings more than 25 years of direct selling and consumer products experience, with a career arc that uniquely combines global brand building, digital transformation, and field organization management.

LFVN: From Foundation to Acceleration - CEO Transition as Inflection Point

<ul><li>Steve Fife reflected on a proactive, strategic, and intentional five-year tenure as CEO, during which LifeVantage transformed into the Activation Company—building out a differentiated product portfolio, overhauling its compensation plan, and investing in digital infrastructure, including an ongoing Shopify implementation.</li><li>Fife will retire in April following nine years with the company.</li><li>The LoveBiome integration is tracking well ahead of typical M&amp;A timelines, with conversations beginning in June 2025, deal close on October 1, and full operational integration by November 1.</li></ul>

Steve Fife reflected on a proactive, strategic, and intentional five-year tenure as CEO, during which LifeVantage transformed into the Activation Company—building out a differentiated product portfolio, overhauling its compensation plan, and investing in digital infrastructure, including an ongoing Shopify implementation.Fife will retire in April following nine years with the company.The LoveBiome integration is tracking well ahead of typical M&amp;A timelines, with conversations beginning in June 2025, deal close on October 1, and full operational integration by November 1.

LFVN: CEO Succession on the Horizon; Healthy Edge Stack Gaining Traction

<ul><li>Integration. The October 2025 acquisition of LoveBiome has progressed with exceptional efficiency.</li><li>Mechanical integration, including ERP systems, compensation plan unification, and payment processing, was completed within one month, enabling combined operations by November 1.</li><li>The integration extends beyond systems to encompass cross-selling between consultant groups, with both sales forces educating one another under the unified “Activation Nation” banner. </li></ul>

Integration. The October 2025 acquisition of LoveBiome has progressed with exceptional efficiency.Mechanical integration, including ERP systems, compensation plan unification, and payment processing, was completed within one month, enabling combined operations by November 1.The integration extends beyond systems to encompass cross-selling between consultant groups, with both sales forces educating one another under the unified “Activation Nation” banner. 

LFVN: WTR Small-Cap Spotlight Recap - 2026 Deemed "The Breakthrough Era"

<div><ul><li>LifeVantage reflected on a transformative 2025, marked by a recovery from the MindBody GLP-1 System inventory stockouts following its successful 4Q24 launch, culminating in the strategic acquisition of LoveBiome.</li><li>Fife characterized the year as continued progress on the company’s multi-year journey that focused on product strategy, compensation plan modernization, and technology investments, including the Shopify partnership that will be launching in 2026.</li><li>The LoveBiome acquisition represents more than product expansion, bringing a team with more than 40 years of direct selling experience and shared vision around science-based products and entrepreneurial opportunity.</li></ul></div>

LifeVantage reflected on a transformative 2025, marked by a recovery from the MindBody GLP-1 System inventory stockouts following its successful 4Q24 launch, culminating in the strategic acquisition of LoveBiome.Fife characterized the year as continued progress on the company’s multi-year journey that focused on product strategy, compensation plan modernization, and technology investments, including the Shopify partnership that will be launching in 2026.The LoveBiome acquisition represents more than product expansion, bringing a team with more than 40 years of direct selling experience and shared vision around science-based products and entrepreneurial opportunity.

LFVN: LoveBiome Integration Ahead of Schedule; P84 Science Validated in Recent Study

United States

Lifevantage Corporation is a health and nutrition company that develops dietary supplements. The Company produces nutritional products that are intended to combat oxidative stress to support brain, eye, and joint function, as well as skin canine products.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Lifevantage (LFVN US)

LFVN: 3QFY26 Softer Than Anticipated; Incoming CEO Likely the Next Catalyst

LFVN reported 3QFY26 results that were below our estimates and stated its FY26 revenue, EBITDA, and EPS are now expected to be at the lower end of...

Water Tower Research

LFVN: From Foundation to Acceleration - CEO Transition as Inflection Point

LifeVantage has named Terrence Moorehead as its next President and CEO, effective August 5, 2026, a board-unanimous selection that reflects a...

Water Tower Research

LFVN: CEO Succession on the Horizon; Healthy Edge Stack Gaining Traction

Steve Fife reflected on a proactive, strategic, and intentional five-year tenure as CEO, during which LifeVantage transformed into the Activation...

Water Tower Research

LFVN: WTR Small-Cap Spotlight Recap - 2026 Deemed "The Breakthrough Era"

Mechanical integration, including ERP systems, compensation plan unification, and payment processing, was completed within one month, enabling...

Water Tower Research

LFVN: LoveBiome Integration Ahead of Schedule; P84 Science Validated in Recent Study

LifeVantage reflected on a transformative 2025, marked by a recovery from the MindBody GLP-1 System inventory stockouts following its...

Water Tower Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)